In a Nov. 10, 2017 research note, analyst Douglas Loe noted that Immunovaccine Inc. (IMV: TSX.V) «
generated cumulative return of 37 % since Echelon Wealth Partners» last update note.
Not exact matches
FL currently earns a third - quintile 10 %
return on invested capital (ROIC) and has
generated a
cumulative $ 762 million (12 % of market cap) in free cash flow (FCF) over the past five years.
The fund severely underperformed in 2008 (
return of -65.5 %) and 2011 -LRB--34.9 %), so despite its recent rebound and other years of outstanding
returns, it has not yet started to
generate a substantial RealAlpha ™ on a
cumulative basis.
«Not only does diversification reduce the variance of portfolio
returns, but non-diversified stock portfolios are subject to the risk that they will fail to include the relatively few stocks that, ex post,
generate large
cumulative returns.
It allows you to
generate credible sequences of
cumulative stock
returns and P / E10 as a function of the initial valuation.
Broadly speaking cash hasn't
generated cumulative real
returns since 1930 or so.
If they are not conservative and
cumulative effects to simulate future climate, they should be removed from the data and the simulation must start from a base temperature to disregard such effects, since these are natural and variables, up and down, nothing can be said that the basis for the temperature increase
generated by CO2 go preserve these values, it can be beyond the natural variation over time, a
return to a point below the current source.